Skip to main content

Advertisement

SpringerLink
Log in

CTLA-4 overexpression in CD19+/CD5+ cells correlates with the level of cell cycle regulators and disease progression in B-CLL patients

  • Correspondence
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2

References

  1. Brunner MC, Chambers CA, Chan FK, Hanke J, Winoto A, Allison JP . CTLA-4-mediated inhibition of early events of T cell proliferation. J Immunol 1999; 162: 5813–5820.

    CAS  PubMed  Google Scholar 

  2. Greenwald RJ, Oosterwegel MA, van der Woude D, Kubal A, Mandelbrot DA, Boussiotis VA et al. CTLA-4 regulates cell cycle progression during a primary immune response. Eur J Immunol 2002; 32: 366–373.

    Article  CAS  Google Scholar 

  3. Wolowiec D, Ciszak L, Kosmaczewska A, Bocko D, Teodorowska R, Frydecka I et al. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia. Haematologica 2001; 86: 1249–1257.

    Google Scholar 

  4. Ligers A, Teleshova N, Marterman T, Huang WX, Hillert J . CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2001; 2: 145–152.

    Article  CAS  Google Scholar 

  5. Rossmann ED, Lewin N, Jeddi-Tehrani M, Osterborg A, Mellstedt H . Intracellular T cell cytokines in patients with B cell chronic lymphocytic leukaemia (B-CLL). Eur J Haematol 2002; 68: 299–306.

    Article  CAS  Google Scholar 

  6. Pistillo MP, Tazzari PL, Palmisano GL, Pierri I, Bolognesi A, Ferlito F et al. CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells. Blood 2003; 101: 202–209.

    Article  CAS  Google Scholar 

  7. Wang XB, Kakoulidou M, Giscombe R, Qiu Q, Huang DR, Pirskanen R et al. Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence. J Neuroimmunol 2002; 130: 224–232.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The work was supported in part by Grant no. 4PO5B 136 18 from the State Committee for Scientific Research (KBN), Poland.

Author information

Author notes

  1. A Kosmaczewska and L Ciszak: These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Experimental Therapy, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla 12, Wroclaw, Poland

    A Kosmaczewska, L Ciszak, K Suwalska & I Frydecka

  2. Department of Hematology, Medical University of Wroclaw, Pasteura 4, Wroclaw, Poland

    D Wolowiec & I Frydecka

Authors
  1. A Kosmaczewska
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L Ciszak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K Suwalska
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D Wolowiec
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I Frydecka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I Frydecka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kosmaczewska, A., Ciszak, L., Suwalska, K. et al. CTLA-4 overexpression in CD19+/CD5+ cells correlates with the level of cell cycle regulators and disease progression in B-CLL patients. Leukemia 19, 301–304 (2005). https://doi.org/10.1038/sj.leu.2403588

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403588

  • Springer Nature Limited

This article is cited by

Search

Navigation